Investigating Gender and Sex Differences in Immune Responses Through Vaccination of Transgender and Cisgender Persons
Abroad (travel likely)RecruitingPHASE4
Conditions
Meningococcal Meningitis, Serogroup B · Transgender Persons · Sex Differences in Immune Response · Vaccination
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
CEVAC, University Hospital Ghent, Belgium, Ghent, Belgium
Contact: Study coordinator (Prof. Dr. Isabel Leroux-Roels, PhD, MD) · isabel.lerouxroels@uzgent.be · +3293322068Contact: Study coordinator (Dr. Valentino D'Onofrio, PhD) · valentino.donofrio@uzgent.be · +3293322068Contact: Principal Investigator (Prof. Dr. Isabel Leroux-Roels, PhD, MD)
Study leads
Prof. Dr. Isabel Leroux-Roels, PhD, MD
Principal Investigator
CEVAC, University Hospital Ghent, Belgium